Advancement in radiotherapy technique in cervical carcinoma
Phase 2
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2019/07/020331
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Carcinoma cervix (FIGO stage IB2 â?? IIIB) undergoing radical RT (IMRT) with / without concurrent chemotherapy followed by HDR brachytherapy (3-4 #) on IGRT compatible LINACS
-Patient informed consent
Exclusion Criteria
-Post hysterectomy
-Patients with HIV, Active tuberculosis, severe cardiac co-morbidities, h/o urinary incontinence.
-Patients requiring Extended field radiation
-Patients to be treated by helical tomotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Organ filling evaluation and factors effecting itTimepoint: 2 years
- Secondary Outcome Measures
Name Time Method Plan of the day treatment approach in cervical carcinomaTimepoint: 2 years